With mild cognitive impairment, an older adult has more thinking or memory problems than peers. Those with the disorder have a higher risk, but not a certainty, of getting dementia. Among the most ...

Measuring insulin resistance with a simple, low-cost blood test can help predict the pace of cognitive decline in patients ...

Scientists have identified a simple blood test that measures insulin resistance which may also help doctors determine which ...

In testing, adults with mild cognitive impairment (MCI) scored lower on the test than adults with normal cognitive function. “When combined with other digital biomarkers, a mobile self ...

Mild Cognitive Impairment (MCI) is a decline in cognitive function that may include compromised memory, language, or critical thinking. It is considered more serious than expected age-related ...

Insulin resistance detected by routine triglyceride-glucose (TyG) index can flag people with early Alzheimer's who are four ...

There is currently no cure for the disease nor any definitive way to predict how quickly Alzheimer’s disease will progress, ...

Mild cognitive impairment affects 12% to 18% of people over 60. For some, symptoms stabilize or improve, especially if caused by treatable issues like depression or medication side effects.

Older adults who’ve developed mild cognitive impairment -- a precursor to dementia and Alzheimer’s -- score lower on a peel-and-sniff test than people with normal brains, according to findings ...

A new study finds that highly educated professionals in the wealthiest third of the population are less likely to develop mild cognitive impairment and have that condition progress to dementia.

The Montreal Cognitive Assessment is a brief screening tool designed to detect mild cognitive impairment and early stages of dementia, particularly Alzheimer's disease.